The independent source for health policy research, polling, and news.
2,221 - 2,240 of 3,938 Results
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of Stat News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
KHN senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharmaâs early OxyContin marketing plan.
The vaccine, BCG, is relatively cheap. But experts caution the therapy could be overhyped and, if proven effective, wind up overpriced.
Daily nursing home payroll records just released by the federal government show the number of nurses and aides dips far below average on some days and consistently plummets on weekends.
Medicaid has struggled for years with poor oversight and billions lost to improper payments. A new report finds that despite their fraud-fighting rhetoric, Medicaid managed-care companies are not as rigorous as they should be in ensuring the integrity of the Medicaid payment system.
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
In this episode of KHNâs âWhat the Health?â Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Anna Edney of Bloomberg News discuss the latest enrollment numbers for the Affordable Care Act, Medicaid work requirements in Kentucky and President Donald Trumpâs proposed government reorganization plan. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
Two Missouri hospitals handed over their operations to a private company that has vastly increased the money the hospitals bring in through their laboratories, even though the lab tests are not done on-site.
Itâs getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drugâs high price and insurance company efforts to restrict the use of coupons that shield patients from it.
Proponents say the residencies provide help dealing with increasingly difficult cases, but some nursing groups contend that the programs are not necessary.
An ER patient can be charged thousands of dollars in âtrauma feesâ â even if they werenât treated for trauma.
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
Dr. Mark McClellan joined Johnson & Johnsonâs board of directors after leaving the FDA, but the connection often isnât mentioned in research papers or public events.
A father and son suffered serious hand injuries nine days apart. They both needed surgery and lots of follow-up occupational therapy to rehab their hands. But insurance paid for just a fraction of those OT bills, and the family owed more than $8,500.
The surgeon and writer has been named to head a project by Amazon, Bershire-Hathway and JP Morgan to reduce health costs. He said he wants to help doctors âdo the right thingâ in delivering care.
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.
KHNâs newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you donât have to.
Š 2026 KFF